Home / Lenalidomide / Italy
IT ATC L04AX04 · updated 2 Nov 2026
Lenalidomide shortage in Italy
Is there a Lenalidomide shortage in Italy?
Yes. As of 2 Nov 2026, 19 Lenalidomide products are reported short in Italy, the first since 11 Jul 2024. The company estimate for the return is 29 Mar 2027. Main reason: increased demand.
Also short in Canada, Spain, Ireland, Austria, Belgium, Switzerland, Czechia, Norway, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | LENALIDOMIDE KRKA discontinuation | KRKA D.D. NOVO MESTO | 11 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE KRKA discontinuation | KRKA D.D. NOVO MESTO | 11 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE KRKA discontinuation | KRKA D.D. NOVO MESTO | 15 Jul 2024 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN discontinuation | MYLAN PHARMACEUTICALS LIMITED | 1 Oct 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE ACCORD discontinuation | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN discontinuation | MYLAN PHARMACEUTICALS LIMITED | 8 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE GRINDEKS discontinuation | AS GRINDEKS | 15 May 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE SUN discontinuation | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 14 Jul 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | LENALIDOMIDE MYLAN discontinuation | MYLAN PHARMACEUTICALS LIMITED | 28 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE SUN discontinuation | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 25 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE SUN discontinuation | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 25 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE MYLAN | MYLAN PHARMACEUTICALS LIMITED | 5 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA discontinuation | OLPHA AS | 18 Oct 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE SUN discontinuation | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 28 Oct 2026 | not given | Increased demand Elevata richiesta |
| IT | LENALIDOMIDE ACCORD discontinuation | ACCORD HEALTHCARE, S.L.U. | 31 Oct 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | LENALIDOMIDE MYLAN anticipated discontinuation | MYLAN PHARMACEUTICALS LIMITED | 5 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA anticipated | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA anticipated | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | LENALIDOMIDE OLPHA anticipated | OLPHA AS | 29 Dec 2026 | 29 Mar 2027 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.